Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genomic Health: predicting the course of an individual's can -- Ignore unavailable to you. Want to Upgrade?

To: idos who wrote (22)	3/27/2007 4:13:48 PM
From: A.J. Mullen	Read Replies (3) \| Respond to of 38

Having started this thread and having stated that I owned shares, I should also say that I no longer own any. I sold mid-Feb having thought more about the competition you noted, Idos. I still like the idea of trolling the genes of previous biopsies to provide a prognosis for a current patient, but I think they'll always be vulnerable to competition. Another company could do the same thing with a different suite of genes and have similar predictive power. GHDX's patents involve their algorithms, and perhaps their choice of genes. Ashley